Harbor Capital Advisors, Inc. Neurocrine Biosciences Inc Transaction History
Harbor Capital Advisors, Inc.
- $2.19 Billion
- Q1 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 431 shares of NBIX stock, worth $46,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
431Holding current value
$46,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
652Shares Held
95.8MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.51 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.08 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$522 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$322 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$271 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...